Bioprinting method marks ‘critical step’ towards ending insulin injections
3D-printed human islets could lead to a more effective and less invasive treatment for type 1 diabetes. The ‘breakthrough’ research was presented by a group of international scientists at the biennial European Society for Organ Transplantation Congress currently taking place in London. The researchers developed a method for 3D printing human islets – insulin-producing cells held in the pancreas – using a customised bioink made from alginate and decellularised human pancreatic tissue. The durable, high-density islet structures remained alive and functional for up to three weeks, during which time they maintained strong insulin responses to glucose, according to the researchers. Bioprinting is a growing field focused on creating functional tissues and organs for transplantation and research…